P2-093: The quantification of the catalytic subunit of telomerase in plasma is a prognostic factor in advanced non-small cell lung cancer (NSCLC) patients

Authors :: Ana Blasco
Maria Jose Safont
Carlos Camps
Rafael Rosell
Miquel Taron
Mireia Muñoz-Navarro
Cristina Baballero
Rafael Sirera
Vega Iranzo
Ramon De Las Penas
Source :: Journal of Thoracic Oncology. (8):S528
Publisher :: International Association for the Study of Lung Cancer. Published by Elsevier Inc.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
Prognostic factor
Telomerase
business.industry
Protein subunit
non-small cell lung cancer (NSCLC)
medicine.disease
Internal medicine
medicine
business
neoplasms

Full Text Access

Tools